Antithrombin Deficiency
Clinical safety and efficacy trial of rhATIII begins
Published in Blood Weekly, January 9th, 2003
This trial will be conducted in those patients who are in high-risk situations for the development of thromboses. The first patient has received treatment in the study. This study is expected to be the final clinical trial before submission for European registration.
The trial is an open-label, single-arm study including at least 12 patients. This is a multinational study conducted primarily in Europe in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-01-09)
More Articles from Blood Weekly
- Bone Marrow Transplantation
Transduction with Fas ligand improves bone marrow engraftment - Stem Cell Transplantation
Peripheral blood stem cell grafts may be linked to lower quality of life - Cell Transplantation
Myeloablation enhances engraftment of transduced murine hematopoietic cells - Peripheral Blood Stem Cell Transplantation
Reduced DMSO levels in peripheral blood concentrate improves cell viability - Stem Cell Transplantation
Granulocyte colony-stimulating factor can hasten pediatric recovery - Stem Cell Transplantation
Human leukocyte antigen alleles affect graft-versus-host disease risk - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
